Sun set sesh is always the best thing ever 🔥📷

🚨 Peer-reviewed article about peer reviewers shows medical journals are bought and paid for by Big Pharma. In a new article published in JAMA, researchers found that half of the peer reviewers in medical journals received nearly a billion dollars in payments from industry. To

$CTEV 6 days after publicly declaring that “the turn has happened,” (in Nov 2025 Q3 conf call) a selling shareholder — the largest shareholder over 30% of the shares — conducted a $75M secondary at $51.50 Today CTEV has EPS miss, shares crumbled. Lucky 30% seller😂

𝗝𝗮𝗴𝘂𝗮𝗿𝘀 𝗲𝗮𝘁 𝗮𝘆𝗮𝗵𝘂𝗮𝘀𝗰𝗮 𝗮𝗻𝗱 𝗮𝗰𝘁 𝗹𝗶𝗸𝗲 𝗸𝗶𝘁𝘁𝗲𝗻𝘀. Deep in the Amazon, the apex predator of the rainforest chews Banisteriopsis caapi — the vine used to make ayahuasca. Then it rolls onto its back. Bats at invisible things in the air. And stares at

$DUOL Nov ’25: “DAU growth stabilized at ~30%, on track for exceptional year.” Feb ’26: Admits deceleration to ~20% in 2026 + strategic pivot hits monetization. Stock tanking in AH

A breathtaking view of the Waterfall of the Bride in Peru.

BlackRock Private credit fund: Price discovery in some private credit portfolios seems to be binary. 100 cents on the dollar to zero 3 months later. So I guess there was no collateral? Alarming to say the least.

"Private credit could be one of the biggest busts we've ever seen on Wall Street," warns Richard Christopher Whalen

Left side is a human lung. Right side is a tree. The tree breathes in what the lung breathes out. The lung breathes in what the tree breathes out. God's design is incredible.

Bill Gates has spent $164,641,795 on Media Outlets to suppress the truth about ‘Vaccine’ injuries and deaths…

$BLK Execs touted “stable” private credit on Jan 15 ’26 earnings call, but hid surging redemptions in $26B HLEND fund. Truth dropped Mar 6—redemption gate triggered, stock plunged 5-8%. Investors misled? $BLK

PepGen Inc. $PEPG told investors its FREEDOM2 trial was “on track.” But the U.S. Food and Drug Administration had already been reviewing problematic preclinical tox data behind the scenes. Then came the truth: ➡️ Partial FDA clinical hold ➡️ Trial disruption ➡️ Stock −26%

$SGRY rejected a $25.75/share buyout from Bain Capital, claiming its standalone growth prospects were stronger and even claimed operational headwinds were “not a long-term trend.” Then came Q4 Co admits “fourth quarter results did not meet our expectations”

Short report on this mornings proceedings in the appeal court in Amsterdam.

$OLMA claimed independence from Roche’s persevERA trial. But same mechanism = class-wide risk. Today Roche flops ; and OLMA tanks 30%. (Just before : $190M offering, CFO exit, $15M insider sales).

$BNTX CRASHING this am on Q4 MISS + founders stepping down. Nov call: “Stable demand… performing within expectations” 🙄 Vaccine franchise was crumbling the whole time. Misled? $BNTX

$SGHT hyped massive growth for their TearCare dry eye tech in 2026, but reality? Just $1.6M revenue in 2025 & stock plunged 35% after truths emerged!

ARQ Inc. $ARQ Investors duped on Corbin GAC disaster—boasted mid-2026 mega-output, but epic design FIASCO throttled it to pathetic 15M lbs! Plant SHUTTERED, $45M write-off BOMB, lawsuit FURY, growth fantasy OBLITERATED

$CDRE After issuing bogus Q4 guidance, and claims, CEO dumps 95% of his stock ($49 million) Ballsy!